A detailed history of Culbertson A N & CO Inc transactions in Amgen Inc stock. As of the latest transaction made, Culbertson A N & CO Inc holds 1,910 shares of AMGN stock, worth $610,684. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,910
Previous 2,150 11.16%
Holding current value
$610,684
Previous $611,000 2.45%
% of portfolio
0.1%
Previous 0.11%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$262.75 - $319.31 $63,060 - $76,634
-240 Reduced 11.16%
1,910 $596,000
Q1 2024

Apr 30, 2024

BUY
$268.87 - $324.56 $51,085 - $61,666
190 Added 9.69%
2,150 $611,000
Q3 2023

Oct 18, 2023

BUY
$218.65 - $271.46 $48,103 - $59,721
220 Added 12.64%
1,960 $526,000
Q1 2023

May 08, 2023

BUY
$225.79 - $275.2 $65,479 - $79,808
290 Added 20.0%
1,740 $420,000
Q3 2022

Oct 13, 2022

BUY
$224.46 - $253.15 $53,870 - $60,756
240 Added 19.83%
1,450 $326,000
Q1 2022

Apr 19, 2022

BUY
$219.27 - $242.57 $265,316 - $293,509
1,210 New
1,210 $292,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Culbertson A N & CO Inc Portfolio

Follow Culbertson A N & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Culbertson A N & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Culbertson A N & CO Inc with notifications on news.